Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome

  • Cori De Santo
  • , Kristin D'Aco
  • , Gabriel C. Araujo
  • , Nora Shannon
  • , D. D.D. Study
  • , Hilary Vernon
  • , April Rahrig
  • , Kristin G. Monaghan
  • , Zhiyv Niu
  • , Patrik Vitazka
  • , Jonathan Dodd
  • , Sha Tang
  • , Linda Manwaring
  • , Arelis Martir-Negron
  • , Rhonda E. Schnur
  • , Jane Juusola
  • , Audrey Schroeder
  • , Vivian Pan
  • , Katherine L. Helbig
  • , Bethany Friedman
  • Marwan Shinawi
  • Washington University St. Louis
  • University of Rochester
  • Nottingham University Hospitals NHS Trust
  • Wellcome Trust Sanger Institute
  • Kennedy Krieger Institute
  • Johns Hopkins University
  • Advocate Health Care
  • OPKO Health, Inc.
  • Baylor College of Medicine
  • Ambry Genetics
  • Nicklaus Children's Hospital

Producción científica › revisión exhaustiva

48 Citas (Scopus)

Resumen

Background Rare de novo mutations have been implicated as a significant cause of idiopathic intellectual disability. Large deletions encompassing 10p11.23 have been implicated in developmental delay, behavioural abnormalities and dysmorphic features, but the genotype-phenotype correlation was not delineated. Mutations in WAC have been recently reported in large screening cohorts of patients with intellectual disability or autism, but no full phenotypic characterisation was described. Methods Clinical and molecular characterisation of six patients with loss-of-function WAC mutations identified by whole exome sequencing was performed. Clinical data were obtained by retrospective chart review, parental interviews, direct patient interaction and formal neuropsychological evaluation. Results Five heterozygous de novo WAC mutations were identified in six patients. Three of the mutations were nonsense, and two were frameshift; all are predicted to cause loss of function either through nonsense-mediated mRNA decay or protein truncation. Clinical findings included developmental delay (6/6), hypotonia (6/6), behavioural problems (5/6), eye abnormalities (5/6), constipation (5/6), feeding difficulties (4/6), seizures (2/6) and sleep problems (2/6). All patients exhibited common dysmorphic features, including broad/prominent forehead, synophrys and/or bushy eyebrows, depressed nasal bridge and bulbous nasal tip. Posteriorly rotated ears, hirsutism, deep-set eyes, thin upper lip, inverted nipples, hearing loss and branchial cleft anomalies were also noted. Conclusions Our case series show that loss-of-function mutations in WAC cause a recognisable genetic syndrome characterised by a neurocognitive phenotype and facial dysmorphism. Our data highly suggest that WAC haploinsufficiency is responsible for most of the phenotypic features associated with deletions encompassing 10p11.23.

Idioma originalEnglish
Páginas (desde-hasta)754-761
Número de páginas8
PublicaciónJournal of Medical Genetics
Volumen52
N.º11
DOI
EstadoPublished - 11 ago 2015
Publicado de forma externaSí

Huella

Profundice en los temas de investigación de 'WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome'. En conjunto forman una huella única.

Citar esto